{"id":5231,"date":"2019-10-22T17:22:29","date_gmt":"2019-10-22T15:22:29","guid":{"rendered":"https:\/\/www.iegt-rostock.de\/projekte_iegt\/4791\/"},"modified":"2020-10-06T10:01:26","modified_gmt":"2020-10-06T08:01:26","slug":"emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy","status":"publish","type":"projekte_iegt","link":"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/","title":{"rendered":"e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy"},"content":{"rendered":"

e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy<\/h1>\n<\/div><\/div>

The project MelAutim addresses the goal to uncover the molecular and cellular mechanisms involved in the interplay between cancer and autoimmunity. In particular, the focus lies on factors involved in the onset of, or the exacerbation of pre-existing autoimmune diseases during immunotherapy regimens against cancer. On this background, a model using the methods of systems biology shall be developed that enables an assessment of a patients\u2019 individual risks before the onset of such therapies. These evaluations will support physicians\u2019 choice of therapy and control intervals. Thereby, therapeutic targets could be identified, that without provoking conditions of autoimmunity. Ultimately, adjustment of this model in that autoimmunity is induced in silico under controlled conditions, leads to further discoveries concerning the pathology of autoimmune diseases. <\/span><\/p>\n

Subproject 1 (SP1): Targeting the crosstalk between melanoma and immune cells by reprogramming the cancer secretome<\/h2>\n

The IEGT subproject investigates how melanoma cells influence immune cells through their secretome, achieving disease progression, immunotherapy resistance and flares of pre-existing autoimmune diseases. The focus will be on the immunomodulatory properties of the melanoma secretome upon upregulation of E2F1 transcription factor in tumor cells. We intend to unveil E2F1\/cofactor\/gene axes which reprogram the secretome towards supporting tumor progression and deregulating immune responses. Using systems pharmacology-based approaches, molecular therapeutics capable of reversing the currently poor clinical outcome will be developed and tested in mouse models.<\/span><\/p>\n<\/div><\/div>

<\/i><\/div>

Project Head (SP1)<\/strong><\/p>\n

Prof. Brigitte P\u00fctzer M.D., Ph.D.
\nRostock University Medical Center
\nInstitute of Experimental Gene Therapy and Cancer Research<\/p>\n<\/div><\/div>

<\/i><\/div>

Research Partners<\/strong><\/p>\n

Prof. Julio Vera (Coordinator)
\nUniversit\u00e4tsklinikum Erlangen
\nLaboratory of Systems Tumor Immunology
\nDepartment of Dermatology<\/p>\n

Prof. Olaf Wolkenhauer
\nUniversity of Rostock
\nDepartment of Systems Biology and Bioinformatics<\/p>\n

Prof. Lucie Heinzerling M.D.
\nUniversit\u00e4tsklinikum Erlangen
\nDepartment of Dermatology<\/p>\n

Prof. Ria Baumgrass
\nSignal Transduction, German Rheumatism Research Center (DRFZ), A Leibniz Institute, Berlin<\/p>\n

Prof. Gerhard Kr\u00f6nke
\nUniversit\u00e4tsklinikum Erlangen
\nDepartment of Internal Medicine 3 – Rheumatology and Immunology
\nNikolaus Fiebiger Center of Molecular Medicine<\/p>\n<\/div><\/div>[vc_btn title=”Project description on sys-med.de” style=”custom” custom_background=”#2f6ca3″ custom_text=”#ffffff” link=”url:https%3A%2F%2Fwww.sys-med.de%2Fde%2Fverbuende%2Fmelautim%2Ftp1%2F”]

This project is funded by the Federal Ministry of Education and Research (BMBF) 01ZX1905D, DLR Projekttr\u00e4ger\u2013 Gesundheit<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div>

[vc_widget_sidebar sidebar_id=”default_sidebar”]
\"\"<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"template":"","projekt_bezeichnung":[184],"acf":[],"yoast_head":"\ne:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy - Institute for Experimental Gentherapy and Cancer Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy - Institute for Experimental Gentherapy and Cancer Research\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Institute for Experimental Gentherapy and Cancer Research\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-06T08:01:26+00:00\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/\",\"url\":\"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/\",\"name\":\"e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy - Institute for Experimental Gentherapy and Cancer Research\",\"isPartOf\":{\"@id\":\"https:\/\/www.iegt-rostock.de\/#website\"},\"datePublished\":\"2019-10-22T15:22:29+00:00\",\"dateModified\":\"2020-10-06T08:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.iegt-rostock.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.iegt-rostock.de\/#website\",\"url\":\"https:\/\/www.iegt-rostock.de\/\",\"name\":\"Institute for Experimental Gentherapy and Cancer Research\",\"description\":\"Cancer Research in Rostock\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.iegt-rostock.de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy - Institute for Experimental Gentherapy and Cancer Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/","og_locale":"en_US","og_type":"article","og_title":"e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy - Institute for Experimental Gentherapy and Cancer Research","og_url":"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/","og_site_name":"Institute for Experimental Gentherapy and Cancer Research","article_modified_time":"2020-10-06T08:01:26+00:00","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/","url":"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/","name":"e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy - Institute for Experimental Gentherapy and Cancer Research","isPartOf":{"@id":"https:\/\/www.iegt-rostock.de\/#website"},"datePublished":"2019-10-22T15:22:29+00:00","dateModified":"2020-10-06T08:01:26+00:00","breadcrumb":{"@id":"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.iegt-rostock.de\/en\/projekte_iegt\/emed-systemmedizinischer-forschungsverbund-melautim-systems-medicine-of-melanomaandautoimmunity-in-thecontext-of-immunotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.iegt-rostock.de\/en\/"},{"@type":"ListItem","position":2,"name":"e:Med Systemmedizinischer Forschungsverbund \u2013 MelAutim \u2013 Systems medicine of melanoma and autoimmunity in the context of immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.iegt-rostock.de\/#website","url":"https:\/\/www.iegt-rostock.de\/","name":"Institute for Experimental Gentherapy and Cancer Research","description":"Cancer Research in Rostock","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.iegt-rostock.de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.iegt-rostock.de\/en\/wp-json\/wp\/v2\/projekte_iegt\/5231"}],"collection":[{"href":"https:\/\/www.iegt-rostock.de\/en\/wp-json\/wp\/v2\/projekte_iegt"}],"about":[{"href":"https:\/\/www.iegt-rostock.de\/en\/wp-json\/wp\/v2\/types\/projekte_iegt"}],"wp:attachment":[{"href":"https:\/\/www.iegt-rostock.de\/en\/wp-json\/wp\/v2\/media?parent=5231"}],"wp:term":[{"taxonomy":"projekt_bezeichnung","embeddable":true,"href":"https:\/\/www.iegt-rostock.de\/en\/wp-json\/wp\/v2\/projekt_bezeichnung?post=5231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}